Beijing Tong Ren Tang Chinese Medicine Co Ltd
HKEX:3613
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| HK |
B
|
Beijing Tong Ren Tang Chinese Medicine Co Ltd
HKEX:3613
|
7.1B HKD |
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
932.1B USD |
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
585.5B USD |
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
257.3B CHF |
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
223.5B GBP |
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
233.6B CHF |
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
285.2B USD |
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD |
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
151.4B USD |
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
120.2B USD |
Loading...
|
Market Distribution
| Min | -3 900% |
| 30th Percentile | 12.5% |
| Median | 26.6% |
| 70th Percentile | 42.7% |
| Max | 905% |
Other Profitability Ratios
Beijing Tong Ren Tang Chinese Medicine Co Ltd
Glance View
Beijing Tong Ren Tang Chinese Medicine Co., Ltd. engages in the manufacture, retail and wholesale of Chinese medicine and healthcare products. The company employs 745 full-time employees The company went IPO on 2013-05-07. Along with subsidiaries, it operates its business through three segments. The Hong Kong segment engages in the sale of Chinese medicine products and healthcare products and provision of Chinese medical consultation and treatments through retail outlets as well as wholesale of Chinese medicine products in Hong Kong. The company is also involved in the royalty fee income from overseas entities using the brand of Tong Ren Tang. The Mainland China segment engages in the wholesale of healthcare products in Mainland China and the sole distribution of Tong Ren Tang branded products of Tong Ren Tang Technologies and Tong Ren Tang Ltd. to customers outside Mainland China. The Overseas segment engages in the retail and wholesale of Chinese medicine products and healthcare products and the provision of Chinese medical consultation and treatments in other overseas countries.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
The current Gross Margin for Beijing Tong Ren Tang Chinese Medicine Co Ltd is 63%, which is below its 3-year median of 66.7%.
Over the last 3 years, Beijing Tong Ren Tang Chinese Medicine Co Ltd’s Gross Margin has decreased from 71.2% to 63%. During this period, it reached a low of 63% on Jun 30, 2025 and a high of 72.1% on Jun 30, 2024.
